This site is intended for healthcare professionals only
LoginRegister
Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag InternationalJnJ to acquire Intra-Cellular Therapies for USD 14.6 billion
bladder cancerPfizer Sasanlimab, BCG combo improves event-free survival in patients with BCG-Naive, High-Risk...
Pharmacy Council sets 1:20 staff to students ratio, tightens faculty rules for B.Pharm programsPharmacy Council sets 1:20 staff to students ratio, tightens faculty rules for B.Pharm programs
Eli Lilly to acquire SiteOne Therapeutics in USD 1 billion dealCopycat weight-loss drugs: Eli Lilly sues two medical spas
GSK buys IDRx for up to USD 1.15 billionEli Lilly to acquire Scorpion Therapeutics mutant-selective PI3Kα inhibitor program
Roche gets negative EMA Committee opinion on Elevidys CMARoche gets USFDA clearance for highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
AstraZeneca Imfinzi approved in EU as immunotherapy for limited stage small cell lung cancerAstraZeneca-Daiichi Sankyo Datopotamab deruxtecan gets USFDA priority review in pretreated...
Sanofi DupixentSanofi Sarclisa gains Chinese nod for treatment of adult patients with relapsed or refractory...
GSK Depemokimab applications accepted for review in China, Japan for asthma with type 2 inflammation, CRSwNPGSK to acquire IDRx for upto USD 1.15 billion
Lupin Manufacturing Solutions: Empagliflozin API gets CADIFA approval from ANVISA, BrazilLupin unveils pregnancy prevention drug Minzoya in US
Ciplas Azithromycin Price Battle: NPPA Increases Ceiling with New RevisionCipla's Azithromycin Price Battle: NPPA Increases Ceiling with New Revision
Fire at MKCG Lab Prompts InspectionHP: Fire erupted at pharma unit in Baddi, no injured
X